P2B-079

Sarcoma Oncology Center (Santa Monica, CA) › P2B-079

P2B-079

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Sarcoma Oncology Center (Santa Monica, CA) · Dr. Reyes
consented 2013-02-22

completed

AEs

3

Serious

0

Dropout signal

–

Adverse events

3

Grade 1 nausea with onset in cycle 5 (2013-06-03); assessed as not related to study drug (unlikely); resolved 2013-06-07.

mild assessed

Grade 1 anaemia with onset in cycle 4 (2013-05-25); assessed as related to study drug (probable); resolved 2013-06-16.

mild assessed

Grade 1 vomiting with onset in cycle 4 (2013-05-11); assessed as not related to study drug (not related); resolved 2013-05-14.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.